Skip to Content

Nevro Corp NVRO

Morningstar Rating
$14.42 +0.85 (6.26%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NVRO is trading at a 41% discount.
Price
$13.63
Fair Value
$74.12
Uncertainty
Very High
1-Star Price
$89.58
5-Star Price
$42.45
Economic Moat
Lfvvj
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NVRO is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$13.57
Day Range
$13.6114.54
52-Week Range
$13.3639.68
Bid/Ask
$12.80 / $22.00
Market Cap
$524.86 Mil
Volume/Avg
290,896 / 489,356

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.22
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
1,215

Comparables

Valuation

Metric
NVRO
MMSI
SIBN
Price/Earnings (Normalized)
25.07
Price/Book Value
1.793.633.80
Price/Sales
1.223.504.38
Price/Cash Flow
20.47
Price/Earnings
NVRO
MMSI
SIBN

Financial Strength

Metric
NVRO
MMSI
SIBN
Quick Ratio
4.823.818.01
Current Ratio
6.375.459.01
Interest Coverage
−12.988.07−13.52
Quick Ratio
NVRO
MMSI
SIBN

Profitability

Metric
NVRO
MMSI
SIBN
Return on Assets (Normalized)
−5.64%9.43%−8.97%
Return on Equity (Normalized)
−11.08%14.77%−12.61%
Return on Invested Capital (Normalized)
−7.81%11.47%−11.78%
Return on Assets
NVRO
MMSI
SIBN
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesCvbskdldFjqpmn$196.9 Bil
SYK
Stryker CorpWkbrnkwjnlVlht$136.5 Bil
MDT
Medtronic PLCHnxtmpkqYzbwmt$115.4 Bil
BSX
Boston Scientific CorpPtngcbxkzSnqynz$100.9 Bil
EW
Edwards Lifesciences CorpFzdqglmpQghmtdl$57.3 Bil
DXCM
DexCom IncJnshwngjTbyf$53.8 Bil
ZBH
Zimmer Biomet Holdings IncLsqqprbykMcds$27.2 Bil
ALGN
Align Technology IncFvghgklwYpfnc$24.6 Bil
PHG
Koninklijke Philips NV ADRZzrgbqznHtsrqcc$18.4 Bil
PODD
Insulet CorpSybzfmrbvfDjnvq$11.8 Bil

Sponsor Center